O&G open
Long-Acting Injectable Buprenorphine in Pregnancy
Par Nacev EC, Prewitt KC, Peng L et 3 autres.
Contenu en anglais
Résumé
Objective
To describe real-world use of long-acting injectable buprenorphine among pregnant individuals with opioid use disorder (OUD), including monthly formulations and initiation among those not previously stable on sublingual buprenorphine.
Methods
We conducted a retrospective chart review of inpatient and outpatient medical records of pregnant individuals with OUD who received at least one dose of long-acting injectable buprenorphine during pregnancy while admitted at a large academic medical center. Dosing patterns, supplemental sublingual buprenorphine use, treatment retention, and maternal outcomes were described.